Teva autoimmune antibody notches ph. 2 win in celiac disease
Teva's experimental antibody TEV-408 hits a key phase IIa endpoint in celiac disease studies.
2 independently detected trends connected to this subject, with the latest coverage first.
This hub groups 2 separate news trends connected to Celiac Disease, spanning August 13, 2026 through September 3, 2026. Each event page combines source coverage, attention velocity and a time-stamped explanation instead of treating every headline as a separate story.
The record below represents 16 article observations and 16 source signals, led by Business, Entertainment coverage. Use it to compare how individual events emerged, spread and changed over time.
Teva's experimental antibody TEV-408 hits a key phase IIa endpoint in celiac disease studies.
'Blue Bloods' star Jennifer Esposito opens up about her past health struggles and recovery.